• Register
  • Login
  • Subscribe
  • Contact Us

Latest Medicinal Product Tenders in Czech Republic 2026

CzechRepublicTenders brings you the latest and most relevant Medicinal Product tenders in Czech Republic, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Medicinal Product and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to CzechRepublicTenders, users gain unlimited access to public procurement notices related to Medicinal Product. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Czech Republic.

Medicinal Products for the Therapy of Cystic Fibrosis 2025-Ii

CZT Ref No.:  117365589

Deadline:  24 Apr 2025

Medicinal Products for the Therapy of Cystic Fibrosis 2025

CZT Ref No.:  117364764

Deadline:  24 Apr 2025

Medicinal Product with the Active Substance of the Uskinumab

CZT Ref No.:  117340090

Deadline:  05 May 2025

Lutecium (177Lu) Oxodotreotid Ii 2024

CZT Ref No.:  117337746

Deadline:  09 May 2025

Medicinal Products with the Active Substance Mirikizumab

CZT Ref No.:  117335959

Deadline:  09 May 2025

Medicinal Products with the Active Ingredient Selperkatinib

CZT Ref No.:  117335649

Deadline:  09 May 2025

Medicinal Products with the Active Ingredient Glofitamab

CZT Ref No.:  117333494

Deadline:  05 May 2025

Fremenezumab Medicinal Products

CZT Ref No.:  117329477

Deadline:  09 May 2025

Medicinal Product with the Active Substance Okrelizumab

CZT Ref No.:  117327436

Deadline:  05 May 2025

  Chat with us